Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03303846 · ClinicalTrials.gov registry record · NA
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients
A NA study of Healthy Subject, sponsored by City of Hope Medical Center.
- Active
- Registry status
- NA
- Development phase
- 344
- Enrollment target
- 5
- Study locations
NCT03303846: Active NA study of Healthy Subject, sponsored by City of Hope Medical Center.
NCT03303846 is a NA study of Healthy Subject that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 344 participants, above the 227-participant average among 16 other Healthy Subject trials with a reported enrollment target (52% higher). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03303846, a NA study of Healthy Subject, is active but no longer recruiting, sponsored by City of Hope Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 344 participants
- Enrollment target
- 5
- Study locations
Study Summary
This clinical trial studies normal breast tissue changes combined with breast magnetic resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast tissue markers in combination with breast imaging such as MRI may help to more accurately assess a woman's risk of developing breast cancer.
Primary Outcome
Development of breast cancers other than triple-negative (e.g. estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) the study analysis, however they will be reported as descriptive statistics.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- PROCEDURE Magnetic Resonance Imaging
- OTHER Laboratory Biomarker Analysis
Study Locations (5)
California
- City of Hope Medical Center - Duarte
- University of Southern California - Los Angeles
North Carolina
- Duke University - Durham
Ohio
- Ohio State University, Stefanie Spielman Comprehensive Breast Center - Columbus
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2017-10-13 |
| Est. Completion | 2026-04-25 |
| Phase | NA |
What the registry record for NCT03303846 still lists
NCT03303846 is an interventional study that assigns participants to a tested intervention. The registered 344 participants enrollment target is mid-sized for trials with a published cap, above the 227-participant average among 16 other Healthy Subject trials with a reported enrollment target (52% higher).
The record links to 1 condition, with Healthy Subject appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT03303846 lists 5 locations in 4 states (California, North Carolina, Ohio).
Frequently Asked Questions
What is clinical trial NCT03303846 about?
NCT03303846 is a clinical study titled "Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients". This clinical trial studies normal breast tissue changes combined with breast magnetic resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast tissue markers in combination with breast imaging such as MRI may help to more accurately assess a woman's risk of develo...
What is the current status of trial NCT03303846?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 344 participants. The study started on 2017-10-13. Estimated completion is 2026-04-25.
What conditions does trial NCT03303846 study?
This clinical trial studies the following conditions: Healthy Subject.
What interventions are being tested in trial NCT03303846?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Magnetic Resonance Imaging (PROCEDURE), Laboratory Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT03303846?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03303846 being conducted?
This trial has 5 study locations across California, North Carolina, Ohio, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subject
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03303846's enrollment target sits among peer trials
344 5th of 16 higher than 12 of 16 other Healthy Subject trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Subject trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
RECRUITING · NA
-
Physical Activity in Promoting Smoking Cessation in African Americans
ACTIVE NOT RECRUITING · NA
-
Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities
ACTIVE NOT RECRUITING · NA
-
Tu Salud Si Cuenta Intervention in Increasing Physical Activity and Healthy Eating Among Latino Families
ACTIVE NOT RECRUITING · NA
-
Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants
COMPLETED · NA
-
Effect of Black Raspberry Phytochemicals on Oral Microbiome in Current Smokers and Non-smokers
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06733363 · 344 participants · Phase 2
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- NCT07179380 · 344 participants · Phase 3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- NCT07304024 · 344 participants · Phase 1
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
- NCT03972657 · 345 participants · Phase 1
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI